Seratrodast

CAS No. 112665-43-7

Seratrodast( AA2414 | A-73001 | ABT-001 )

Catalog No. M10444 CAS No. 112665-43-7

Seratrodast (INN) is a thromboxane A2 (TXA2) receptor (TP receptor) antagonist used primarily in the treatment of asthma.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 35 In Stock
10MG 32 In Stock
25MG 58 In Stock
50MG 79 In Stock
100MG 114 In Stock
200MG Get Quote In Stock
500MG 276 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Seratrodast
  • Note
    Research use only, not for human use.
  • Brief Description
    Seratrodast (INN) is a thromboxane A2 (TXA2) receptor (TP receptor) antagonist used primarily in the treatment of asthma.
  • Description
    Seratrodast (INN) is a thromboxane A2 (TXA2) receptor (TP receptor) antagonist used primarily in the treatment of asthma. It was the first TP receptor antagonist that was developed as an anti-asthmatic drug and received marketing approval in Japan in 1997.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    AA2414 | A-73001 | ABT-001
  • Pathway
    Chromatin/Epigenetic
  • Target
    COX
  • Recptor
    COX| TXA2R
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    112665-43-7
  • Formula Weight
    354.44
  • Molecular Formula
    C22H26O4
  • Purity
    >98% (HPLC)
  • Solubility
    Soluble in Water
  • SMILES
    O=C(O)CCCCCC(C(C1=O)=C(C)C(C(C)=C1C)=O)C2=CC=CC=C2
  • Chemical Name
    (+-)-7-(3,5,6-Trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Endo S, Akiyama K. Nihon Rinsho. 1996 Nov;54(11):3045-8.
molnova catalog
related products
  • COX-2-IN-6

    COX-2-IN-6 is a potent, selective, and orally available cyclooxygenase-2 (COX-2) inhibitor with an IC50 of 0.84 μM and a Ki of 69 nM.COX-2-IN-6 inhibits COX-2-driven PGE2 synthesis with an IC50 of 0.60 μM.COX-2-IN-6 is used to prevent colorectal cancer.

  • LM-1685

    LM-1685 is a potent and selective inhibitor of COX-2 IN human monocytes and whole blood with IC50 of 0.65μM and IC50 = 4.3μM, respectively, and is a potential compound for the treatment of inflammation.

  • Hydroxytoluic acid

    The salts or esters of salicylic acids, or salicylate esters of an organic acid.